company background image
GSK N logo

GSK BMV:GSK N Stock Report

Last Price

Mex$665.00

Market Cap

Mex$1.4t

7D

-10.7%

1Y

n/a

Updated

21 Nov, 2024

Data

Company Financials +

GSK N Stock Overview

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. More details

GSK N fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends2/6

GSK plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GSK
Historical stock prices
Current Share PriceUK£665.00
52 Week HighUK£775.31
52 Week LowUK£624.60
Beta0.33
11 Month Change-14.23%
3 Month Changen/a
1 Year Changen/a
33 Year Change-39.55%
5 Year Change-37.92%
Change since IPO-17.48%

Recent News & Updates

Recent updates

Shareholder Returns

GSK NMX PharmaceuticalsMX Market
7D-10.7%-2.2%-0.9%
1Yn/a-20.7%-4.7%

Return vs Industry: Insufficient data to determine how GSK N performed against the MX Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how GSK N performed against the MX Market.

Price Volatility

Is GSK N's price volatile compared to industry and market?
GSK N volatility
GSK N Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement6.6%
Market Average Movement4.0%
10% most volatile stocks in MX Market6.1%
10% least volatile stocks in MX Market2.6%

Stable Share Price: GSK N's share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine GSK N's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
171570,212Emma Walmsleywww.gsk.com

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines.

GSK plc Fundamentals Summary

How do GSK's earnings and revenue compare to its market cap?
GSK N fundamental statistics
Market capMex$1.36t
Earnings (TTM)Mex$64.51b
Revenue (TTM)Mex$804.44b

21.1x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GSK N income statement (TTM)
RevenueUK£31.31b
Cost of RevenueUK£8.65b
Gross ProfitUK£22.67b
Other ExpensesUK£20.15b
EarningsUK£2.51b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.62
Gross Margin72.39%
Net Profit Margin8.02%
Debt/Equity Ratio119.4%

How did GSK N perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

99%

Payout Ratio

Does GSK N pay a reliable dividends?

See GSK N dividend history and benchmarks
When do you need to buy GSK N by to receive an upcoming dividend?
GSK dividend dates
Ex Dividend DateNov 15 2024
Dividend Pay DateJan 09 2025
Days until Ex dividend7 days
Days until Dividend pay date48 days

Does GSK N pay a reliable dividends?

See GSK N dividend history and benchmarks